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Allergic fungal rhinosinusitis (AFRS) is characterized by
the growth of fungi, mostly Aspergillus sp., in the parana-
sal sinuses together with the formation of nasal polyps,
peanut-butter like “allergic mucin” with fungal hyphae and
typical CT-findings, as well as increased serum total IgE
and Aspergillus-specific IgE concentrations. We here
hypothesize that the increase in serum total IgE is caused
by the local symbiosis of Asp. sp. with Staphylococcus aur-
eus, a germ which is known for the production of entero-
toxins with superantigenic properties. We demonstrate
the presence of S. aureus specific IgE antibodies in the
sera of AFRS patients, correlating with total serum IgE
concentrations, as well as the coexistence of both, A. fumi-
gatus and S. aureus, in biofilm-like formations on the sinus
mucosa. Similar mechanisms and findings may apply for
Allergic Broncho-Pulmonary Aspergillosis/Mykosis
(ABPA/M). This knowledge may result in new diagnostic
and therapeutic approaches including anti-IgE strategies.
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